PDX model

Leveraging its wealth of information on more than 400 fully characterized proprietary patients derived xenografts (PDX) in the portfolio, Creative Biolabs is dedicated to helping scientists in immuno-oncology research and providing the most appropriate PDX models for pre-clinical testing.

Our PDX Model Portfolio

Patient derived xenografted (PDX) models.

Our PDX models offer extensive backgrounds/characterization and represent almost all tissue types and cancer types. Over 400 PDX models are available to engraft into immunocompromised mice and humanized mice and ship to your facility or to use in preclinical testing studies guided by Creative Biolabs. Our PDX model portfolio includes:

✔ Various xenografted models including subcutaneous, orthotopic and disseminated models;

✔ Extensive background on patients’ treatment and molecular/pharmacological characterization;

✔ Corresponding CDX models available;

✔ One-stop platform from animal models to in vivo efficacy studies;

✔ Identification and analysis of biomarkers of in-house PDX models;

✔ PDX models using immunocompromised mice or humanized mice.

New PDX models are still being developed through continuous collaborations with major hospitals.